Gujarat Terce Laboratories reported a net loss of ₹17.81 lakh for the first quarter ended June 30, 2026 (Q1FY27), widening from a net loss of ₹4.35 lakh in the corresponding period of FY26. The deterioration in profitability was driven by a 17.1% year-on-year decline in revenue from operations to ₹900.24 lakh, which outpaced the reduction in cost of materials consumed. This marks a shift from the profitable trajectory seen in Q4FY26, where the company posted a net profit of ₹10.10 lakh.

The Board of Directors approved the unaudited standalone financial results on August 7, 2026, in compliance with Regulations 30 and 33 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The results were subjected to a limited review by the statutory auditor, Shah Doshi Patel & Associates LLP, who issued an unmodified limited review report. The company operates in the pharmaceutical segment and has prepared its financial statements in accordance with Indian Accounting Standards (Ind AS).

Financial Performance Breakdown

Revenue from operations stood at ₹900.24 lakh in Q1FY27, down from ₹1,085.36 lakh in Q1FY26 and ₹1,139.93 lakh in Q4FY26. Total revenue, including other income of ₹48.23 lakh, amounted to ₹948.47 lakh. Other income saw a significant increase compared to ₹9.48 lakh in the previous year, contributing partially to offsetting operational pressures.

Expenses totaled ₹963.35 lakh, resulting in an operating loss before tax of ₹14.88 lakh. Cost of materials consumed dropped sharply to ₹13.51 lakh from ₹198.38 lakh in Q1FY26, indicating improved input cost management or lower production volumes. However, employee benefit expenses remained high at ₹372.64 lakh, and other expenses were ₹254.39 lakh. Finance costs increased slightly to ₹3.24 lakh from ₹4.93 lakh in the prior year quarter.

What the Numbers Show

The financial data reveals a divergence between cost control and revenue generation. While the company successfully reduced its cost of materials consumed by over 93% year-on-year, this efficiency did not translate into profitability due to a nearly 17% contraction in top-line revenue. The surge in other income to ₹48.23 lakh, up from ₹9.48 lakh in Q1FY26, highlights a growing reliance on non-operational income streams to cushion the bottom line. With employee benefits constituting the largest expense category at ₹372.64 lakh, fixed cost leverage remains a challenge as revenues decline. The widening net loss suggests that current revenue levels are insufficient to cover the company’s fixed operational overheads, despite the sharp reduction in variable material costs.

Gujarat Terce Laboratories reported a consolidated net profit of ₹205.41 crore for the quarter ended June 30, 2026, marking a 12.3% year-on-year increase from ₹183.00 crore in Q1FY25. Revenue from operations expanded to ₹4,170.47 crore, up from ₹3,267.96 crore in the corresponding period last year. The growth reflects strong operational performance across its chemical manufacturing segments, with earnings per share (EPS) standing at ₹0.42.

The results were approved by the Board of Directors and reviewed by the Audit Committee. The financial statements were prepared in accordance with Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013. The statutory auditors carried out a limited review of the unaudited financial results. The full format of the financial results has been filed with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Highlights

Standalone revenue from operations remained consistent with consolidated figures at ₹4,170.47 crore. Standalone profit after tax was reported at ₹205.73 crore, compared to ₹183.21 crore in Q1FY25. The paid-up equity share capital stands at ₹4,881.00 crore, with a face value of ₹10 per share.

Corporate Actions

The company announced that its 41st Annual General Meeting (AGM) will be held on Friday, August 21, 2026, at 12:00 noon via Video Conferencing/Other Audio Visual Means (VC/OAVM). Members are provided with the facility to cast their votes using the electronic voting system provided by Bigshare Services Private Limited. The remote e-voting period commences on Tuesday, August 18, 2026, at 9:00 a.m. and ends on Thursday, August 20, 2026, at 5:00 p.m.

The Register of Members and Share Transfer Books will remain closed from Saturday, August 15, 2026, to Friday, August 21, 2026, both days inclusive, for the purpose of the AGM. The cut-off date for determining voting rights is Friday, August 14, 2026. Shareholders holding shares as on this date are eligible to vote. The notice convening the AGM and the annual report are available on the company’s website at www.gujaratterce.in .

What the Numbers Show

The 27.6% year-on-year growth in revenue from operations outpaced the 12.3% growth in net profit after tax, suggesting a slight compression in net margins during the quarter. While top-line expansion was robust, the lower proportional increase in bottom-line earnings indicates potential pressure on operating efficiencies or higher input costs relative to sales growth. Investors should monitor subsequent quarters to determine if this margin trend persists or if operational leverage improves as revenue scales further.